Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Tel Aviv - Delayed Quote ILA

Novolog (Pharm-Up 1966) Ltd (NVLG.TA)

Compare
158.50
+1.50
+(0.95%)
As of 1:17:11 PM GMT+3. Market Open.
Currency in ILS All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,021,602
2,021,602
1,643,489
1,507,949
1,255,248
Cost of Revenue
1,840,824
1,840,824
1,474,323
1,332,435
1,106,291
Gross Profit
180,778
180,778
169,166
175,514
148,957
Operating Expense
110,864
110,864
118,694
97,638
81,097
Operating Income
69,914
69,914
50,472
77,876
67,860
Net Non Operating Interest Income Expense
-3,499
-3,499
-848
-6,998
-7,193
Pretax Income
58,126
58,126
1,730
72,503
61,769
Tax Provision
16,688
16,688
10,474
16,983
15,305
Net Income Common Stockholders
39,538
39,538
-42,003
47,510
42,318
Diluted NI Available to Com Stockholders
39,538
39,538
-42,003
47,510
42,318
Basic EPS
0.08
--
-0.08
0.09
0.08
Diluted EPS
0.08
--
-0.08
0.09
0.08
Basic Average Shares
510,731
--
509,815
507,272
505,452
Diluted Average Shares
510,731
--
510,922
515,793
515,076
Total Operating Income as Reported
62,347
62,347
2,652
78,146
69,935
Rent Expense Supplemental
24,932
24,932
25,165
21,041
18,189
Total Expenses
1,951,688
1,951,688
1,593,017
1,430,073
1,187,388
Net Income from Continuing & Discontinued Operation
39,538
39,538
-42,003
47,510
42,318
Normalized Income
58,315.81
58,315.81
51,124.03
48,427.38
43,065.71
Interest Income
12,896
12,896
12,020
5,539
2,499
Interest Expense
12,608
12,608
12,868
12,537
8,468
Net Interest Income
-3,499
-3,499
-848
-6,998
-7,193
EBIT
70,734
70,734
14,598
85,040
70,237
EBITDA
149,390
149,390
130,139
138,526
115,925
Reconciled Cost of Revenue
1,840,824
1,840,824
1,474,323
1,332,435
1,106,291
Reconciled Depreciation
78,656
78,656
115,541
53,486
45,688
Net Income from Continuing Operation Net Minority Interest
39,538
39,538
-42,003
47,510
42,318
Total Unusual Items Excluding Goodwill
-11,575
-11,575
-55,139
-1,198
-994
Total Unusual Items
-1,049
-1,049
-4,469
-1,198
-994
Normalized EBITDA
150,439
150,439
134,608
139,724
116,919
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-3,323.19
-3,323.19
-12,681.97
-280.62
-246.29
12/31/2021 - 2/28/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade